Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Medtronic ( (MDT) ) is now available.
Medtronic announced the appointment of Thierry Pieton as Chief Financial Officer effective March 3, 2025. Pieton, who will report to CEO Geoff Martha, joins from Renault Group where he was CFO since March 2022. His extensive experience includes roles at Nissan, GE, and PwC, where he demonstrated strong financial leadership and innovation-driven growth, which aligns with Medtronic’s strategic financial goals. The appointment is expected to enhance Medtronic’s financial operations and strategic initiatives, contributing to its mission of transforming healthcare technology.
More about Medtronic
Medtronic plc, headquartered in Galway, Ireland, is a leading global healthcare technology company dedicated to addressing significant health challenges by developing innovative solutions. The company operates in over 150 countries, employing more than 95,000 people, and offers a diverse range of technologies and therapies that treat 70 health conditions, including cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems.
YTD Price Performance: 9.80%
Average Trading Volume: 6,589,511
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $112.9B
For a thorough assessment of MDT stock, go to TipRanks’ Stock Analysis page.
